Literature DB >> 19932271

Selective right ventricular unloading and novel technical concepts in Ebstein's anomaly.

Sunil P Malhotra1, Ed Petrossian, V Mohan Reddy, Mary Qiu, Katsushide Maeda, Sam Suleman, Malcolm MacDonald, Olaf Reinhartz, Frank L Hanley.   

Abstract

BACKGROUND: Favorable outcomes in Ebstein's anomaly are predicated on tricuspid valve competence and right ventricular function. Successful valve repair should be aggressively pursued to avoid the morbidity of prosthetic tricuspid valve replacement. We report our experience with valve-sparing intracardiac repair, emphasizing novel concepts and techniques of valve repair supplemented by selective bidirectional Glenn (BDG).
METHODS: Between June 1993 and December 2008, 57 nonneonatal patients underwent Ebstein's anomaly repairs. The median age at operation was 8.1 years. All were symptomatic in New York Heart Association (NYHA) functional class II (n = 38), III (n = 17), or IV (n = 1). Preoperatively, 26 had mild or moderate cyanosis at rest. We used a number of valve reconstructive techniques that differed substantially from those currently described. BDG was performed in 31 patients (55%) who met specific criteria.
RESULTS: No early or late deaths occurred. At the initial repair, 3 patients received a prosthetic valve. Four patients required reoperation for severe tricuspid regurgitation. Repeat repairs were successful in 2 patients. At follow-up (range, 3 months to 6 years), all patients were acyanotic and in NYHA class I. Tricuspid regurgitation was mild or less in 49 (86%) and moderate in 6 (11%). Freedom from a prosthesis was 91% (52 of 57).
CONCLUSIONS: Following a protocol using BDG for ventricular unloading in selected patients with Ebstein's anomaly can achieve a durable valve-sparing repair using the techniques described. Excellent functional midterm outcomes can be obtained with a selective one and a half ventricle approach to Ebstein's anomaly.

Entities:  

Mesh:

Year:  2009        PMID: 19932271     DOI: 10.1016/j.athoracsur.2009.07.019

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Narrative review of Ebstein's anomaly beyond childhood: Imaging, surgery, and future perspectives.

Authors:  Stephan Neumann; André Rüffer; Jörg Sachweh; Daniel Biermann; Jochen Herrmann; Michael Jerosch-Herold; Mark Hazekamp; Christoph Sinning; Elvin Zengin; Stefan Blankenberg; Evaldas Girdauskas; Hermann Reichenspurner; Torben Kehl; Götz Müller; Rainer Kozlik-Feldmann; Carsten Rickers
Journal:  Cardiovasc Diagn Ther       Date:  2021-12

Review 2.  Ebstein's Anomaly: From Fetus to Adult-Literature Review and Pathway for Patient Care.

Authors:  Tristan K W Ramcharan; Donna A Goff; Christopher E Greenleaf; Suhair O Shebani; Jorge D Salazar; Antonio F Corno
Journal:  Pediatr Cardiol       Date:  2022-04-23       Impact factor: 1.838

3.  Late-Onset Cyanosis and Finger Clubbing in a 37-Year-Old Female with Ebstein's Anomaly and Atrial Septal Defect.

Authors:  Kook-Jin Chun; Dong Cheul Han; Yong Hyun Park; Sang-Kwon Lee
Journal:  Acta Cardiol Sin       Date:  2013-11       Impact factor: 2.672

4.  Current spectrum of surgical procedures performed for Ebstein's malformation: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database.

Authors:  Ryan R Davies; Sara K Pasquali; Marshall L Jacobs; Jeffrey J Jacobs; Amelia S Wallace; Christian Pizarro
Journal:  Ann Thorac Surg       Date:  2013-09-23       Impact factor: 4.330

5.  Outcomes of Ebstein's Anomaly Patients Treated with Tricuspid Valvuloplasty or Tricuspid Valve Replacement: Experience of a Single Center.

Authors:  Bin Li; Han-Song Sun; Shi-Wei Pan; Jian-Ping Xu
Journal:  Chin Med J (Engl)       Date:  2018-05-05       Impact factor: 2.628

6.  Ebstein's Anomaly: "The One and a Half Ventricle Heart".

Authors:  Amber Malhotra; Vishal Agrawal; Kartik Patel; Mausam Shah; Kamal Sharma; Pranav Sharma; Sumbul Siddiqui; Nilesh Oswal; Himani Pandya
Journal:  Braz J Cardiovasc Surg       Date:  2018 Jul-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.